Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(Reuters) Apr 24, 2018 - The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca clinical study.
Read Article
(PharmaTimes [UK]) Apr 24, 2018 - European regulators have kicked off a review of MSD’s Keytruda/pemetrexed combination for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC).
Read Article
Latest Articles
April 24, 2018
April 24, 2018
April 24, 2018
April 24, 2018
April 23, 2018
April 23, 2018
April 23, 2018
April 20, 2018
View More
News Commentary
Editor Image
27 Apr, 2017 | by Howard S. Hochster, MD
It is not difficult to imagine that PARP inhibitors, which function through the...
View Comment
Editor Image
01 May, 2017 | by H. Jack West, MD
The data with brigatinib are strong, as this is an agent that has impressive...
View Comment
View More
OBR Green
There are no Lung (includes NSCLC, SCLC, Mesothelioma) OBR Green articles.
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.